The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Urinary-activated HGF as a noninvasive biomarker for the diagnosis of prostate cancer.
C. R. Peng
No relevant relationships to disclose
A. J. Prager
No relevant relationships to disclose
E. Lita
No relevant relationships to disclose
M. H. Wernick
No relevant relationships to disclose
D. McNally
No relevant relationships to disclose
A. Kaushal
No relevant relationships to disclose
M. Sproull
No relevant relationships to disclose
K. Compton
No relevant relationships to disclose
W. L. Dahut
No relevant relationships to disclose
W. D. Figg
No relevant relationships to disclose
K. A. Camphausen
No relevant relationships to disclose